| Product Code: ETC13276284 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Gastric Cancer Market was valued at USD 5.6 Billion in 2024 and is expected to reach USD 8.2 Billion by 2031, growing at a compound annual growth rate of 5.00% during the forecast period (2025-2031).
The Global Gastric Cancer Market is witnessing significant growth driven by increasing incidence and prevalence of gastric cancer worldwide. Factors contributing to market expansion include advancements in diagnostic technologies, rising awareness about early detection, and the development of innovative treatment options. The market is characterized by a competitive landscape with key players focusing on research and development activities to introduce novel therapies and improve patient outcomes. Additionally, the market is influenced by factors such as changing lifestyle patterns, dietary habits, and aging population demographics. Collaboration between pharmaceutical companies, research institutions, and healthcare providers is crucial for driving progress in the diagnosis, treatment, and management of gastric cancer, ultimately aiming to improve survival rates and quality of life for patients globally.
The Global Gastric Cancer Market is experiencing significant growth due to advancements in precision medicine, targeted therapies, and immunotherapies. Personalized treatment approaches based on genetic profiling are becoming more common, leading to improved outcomes for patients. Additionally, the rise of companion diagnostics is allowing for the identification of suitable patients for specific treatments, enhancing the efficacy of therapies. The market is also witnessing a shift towards minimally invasive surgical techniques and the development of innovative diagnostic tools for early detection. Opportunities exist for pharmaceutical companies to invest in research and development of novel therapies, diagnostic methods, and treatment protocols. Collaboration between industry players, healthcare providers, and research institutions is crucial for driving further advancements in the diagnosis and treatment of gastric cancer.
The Global Gastric Cancer Market faces several challenges, including limited early detection methods leading to late-stage diagnoses, high treatment costs, and the lack of targeted therapies. Additionally, the complexity of gastric cancer biology and the heterogeneity of the disease make it challenging to develop effective treatment strategies. Furthermore, there is a need for increased awareness about gastric cancer risk factors and symptoms among the general population, as early detection plays a crucial role in improving patient outcomes. Access to quality healthcare services and advanced treatment options is also a significant challenge in many regions, particularly in low- and middle-income countries, leading to disparities in patient care and outcomes within the global market.
The global gastric cancer market is primarily driven by factors such as the increasing prevalence of gastric cancer worldwide, advancements in diagnostic technologies for early detection, and the growing adoption of targeted therapies and immunotherapies for treatment. Additionally, the rising geriatric population, lifestyle factors such as smoking, unhealthy diet, and obesity, as well as the development of personalized medicine approaches are contributing to the market growth. Furthermore, ongoing research and development activities focused on innovative treatment options, as well as collaborations between pharmaceutical companies and research institutions, are expected to further drive the market expansion. Overall, the increasing awareness about gastric cancer, improvements in healthcare infrastructure, and the emphasis on early screening and diagnosis are key factors propelling the growth of the global gastric cancer market.
Government policies related to the Global Gastric Cancer Market vary by country but generally focus on improving early detection, treatment access, and research funding. Many governments have implemented screening programs to detect gastric cancer at early stages, while also investing in training healthcare professionals to enhance diagnosis and treatment capabilities. Some countries provide subsidies or financial support for cancer treatments, including surgeries, chemotherapy, and radiation therapy. Additionally, governments allocate funding for research institutions and organizations to conduct studies on gastric cancer prevention, treatment innovations, and improving patient outcomes. Overall, government policies aim to reduce the burden of gastric cancer by promoting awareness, ensuring affordability of treatments, and advancing medical research in the field.
The Global Gastric Cancer Market is expected to witness significant growth in the coming years, driven by factors such as increasing incidence rates of gastric cancer, advancements in diagnostic techniques, and the development of novel treatment options. The market is likely to see a rise in targeted therapies and immunotherapies, as well as personalized medicine approaches tailored to individual patient profiles. Additionally, the growing emphasis on early detection and screening programs is anticipated to drive market growth. However, challenges such as high treatment costs, limited access to healthcare in certain regions, and the complex nature of gastric cancer biology may hinder market expansion. Overall, the Global Gastric Cancer Market is poised for growth, with a focus on innovation and improving patient outcomes.
In the global gastric cancer market, Asia accounts for the largest share due to the high prevalence of gastric cancer in countries like Japan, South Korea, and China. North America follows closely behind with a significant market share attributed to advanced healthcare infrastructure and growing awareness about early detection. Europe also holds a considerable market share with increasing research investments and a rising geriatric population at higher risk. The Middle East and Africa region is witnessing a growing burden of gastric cancer, primarily due to lifestyle factors and limited access to healthcare services. Latin America shows potential for market growth with improving healthcare facilities and increasing focus on cancer treatment initiatives. Overall, these regional insights highlight the diverse factors influencing the global gastric cancer market landscape.
Global Gastric Cancer Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Gastric Cancer Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Gastric Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Global Gastric Cancer Market - Industry Life Cycle |
3.4 Global Gastric Cancer Market - Porter's Five Forces |
3.5 Global Gastric Cancer Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Gastric Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Gastric Cancer Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.8 Global Gastric Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Global Gastric Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 Global Gastric Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Global Gastric Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.12 Global Gastric Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Gastric Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Gastric Cancer Market Trends |
6 Global Gastric Cancer Market, 2021 - 2031 |
6.1 Global Gastric Cancer Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Gastric Cancer Market, Revenues & Volume, By Adenocarcinoma, 2021 - 2031 |
6.1.3 Global Gastric Cancer Market, Revenues & Volume, By Lymphoma, 2021 - 2031 |
6.1.4 Global Gastric Cancer Market, Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021 - 2031 |
6.1.5 Global Gastric Cancer Market, Revenues & Volume, By Carcinoid Tumor, 2021 - 2031 |
6.1.6 Global Gastric Cancer Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Gastric Cancer Market, Revenues & Volume, By Stages, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Gastric Cancer Market, Revenues & Volume, By Stage I, 2021 - 2031 |
6.2.3 Global Gastric Cancer Market, Revenues & Volume, By Stage II, 2021 - 2031 |
6.2.4 Global Gastric Cancer Market, Revenues & Volume, By Stage III, 2021 - 2031 |
6.2.5 Global Gastric Cancer Market, Revenues & Volume, By Stage IV, 2021 - 2031 |
6.2.6 Global Gastric Cancer Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Gastric Cancer Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Gastric Cancer Market, Revenues & Volume, By Endoscopy, 2021 - 2031 |
6.3.3 Global Gastric Cancer Market, Revenues & Volume, By Biopsy, 2021 - 2031 |
6.3.4 Global Gastric Cancer Market, Revenues & Volume, By Imaging Tests, 2021 - 2031 |
6.3.5 Global Gastric Cancer Market, Revenues & Volume, By Exploratory Surgery, 2021 - 2031 |
6.3.6 Global Gastric Cancer Market, Revenues & Volume, By Other, 2021 - 2031 |
6.4 Global Gastric Cancer Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Gastric Cancer Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.4.3 Global Gastric Cancer Market, Revenues & Volume, By Radiation Therapy, 2021 - 2031 |
6.4.4 Global Gastric Cancer Market, Revenues & Volume, By Chemotherapy, 2021 - 2031 |
6.4.5 Global Gastric Cancer Market, Revenues & Volume, By Targeted Therapy, 2021 - 2031 |
6.4.6 Global Gastric Cancer Market, Revenues & Volume, By Palliative Care, 2021 - 2031 |
6.4.7 Global Gastric Cancer Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Gastric Cancer Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Gastric Cancer Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.5.3 Global Gastric Cancer Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.5.4 Global Gastric Cancer Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Global Gastric Cancer Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Gastric Cancer Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.6.3 Global Gastric Cancer Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.6.4 Global Gastric Cancer Market, Revenues & Volume, By Speciality Centres, 2021 - 2031 |
6.6.5 Global Gastric Cancer Market, Revenues & Volume, By Others, 2021 - 2031 |
6.7 Global Gastric Cancer Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Global Gastric Cancer Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.7.3 Global Gastric Cancer Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.7.4 Global Gastric Cancer Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Gastric Cancer Market, Overview & Analysis |
7.1 North America Gastric Cancer Market Revenues & Volume, 2021 - 2031 |
7.2 North America Gastric Cancer Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Gastric Cancer Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Gastric Cancer Market, Revenues & Volume, By Stages, 2021 - 2031 |
7.5 North America Gastric Cancer Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.6 North America Gastric Cancer Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.7 North America Gastric Cancer Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8 North America Gastric Cancer Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.9 North America Gastric Cancer Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Gastric Cancer Market, Overview & Analysis |
8.1 Latin America (LATAM) Gastric Cancer Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Gastric Cancer Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Gastric Cancer Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Gastric Cancer Market, Revenues & Volume, By Stages, 2021 - 2031 |
8.5 Latin America (LATAM) Gastric Cancer Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.6 Latin America (LATAM) Gastric Cancer Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.7 Latin America (LATAM) Gastric Cancer Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.8 Latin America (LATAM) Gastric Cancer Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.9 Latin America (LATAM) Gastric Cancer Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Gastric Cancer Market, Overview & Analysis |
9.1 Asia Gastric Cancer Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Gastric Cancer Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Gastric Cancer Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Gastric Cancer Market, Revenues & Volume, By Stages, 2021 - 2031 |
9.5 Asia Gastric Cancer Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.6 Asia Gastric Cancer Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.7 Asia Gastric Cancer Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.8 Asia Gastric Cancer Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.9 Asia Gastric Cancer Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Gastric Cancer Market, Overview & Analysis |
10.1 Africa Gastric Cancer Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Gastric Cancer Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Gastric Cancer Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Gastric Cancer Market, Revenues & Volume, By Stages, 2021 - 2031 |
10.5 Africa Gastric Cancer Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.6 Africa Gastric Cancer Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.7 Africa Gastric Cancer Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.8 Africa Gastric Cancer Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.9 Africa Gastric Cancer Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Gastric Cancer Market, Overview & Analysis |
11.1 Europe Gastric Cancer Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Gastric Cancer Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Gastric Cancer Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Gastric Cancer Market, Revenues & Volume, By Stages, 2021 - 2031 |
11.5 Europe Gastric Cancer Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.6 Europe Gastric Cancer Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.7 Europe Gastric Cancer Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.8 Europe Gastric Cancer Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.9 Europe Gastric Cancer Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Gastric Cancer Market, Overview & Analysis |
12.1 Middle East Gastric Cancer Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Gastric Cancer Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Gastric Cancer Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Gastric Cancer Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Gastric Cancer Market, Revenues & Volume, By Stages, 2021 - 2031 |
12.5 Middle East Gastric Cancer Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.6 Middle East Gastric Cancer Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.7 Middle East Gastric Cancer Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.8 Middle East Gastric Cancer Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.9 Middle East Gastric Cancer Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Gastric Cancer Market Key Performance Indicators |
14 Global Gastric Cancer Market - Export/Import By Countries Assessment |
15 Global Gastric Cancer Market - Opportunity Assessment |
15.1 Global Gastric Cancer Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Gastric Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Gastric Cancer Market Opportunity Assessment, By Stages, 2021 & 2031F |
15.4 Global Gastric Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.5 Global Gastric Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.6 Global Gastric Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.7 Global Gastric Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.8 Global Gastric Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Gastric Cancer Market - Competitive Landscape |
16.1 Global Gastric Cancer Market Revenue Share, By Companies, 2024 |
16.2 Global Gastric Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |